Rocket Pharmaceuticals, Inc.Rocket Pharmaceuticals, Inc.Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

49.330.00 0.00%
The 12 analysts offering 1 year price forecasts for RCKT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 14 analysts giving stock ratings to RCKT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

RCKT EPS for the last quarter is −0.64 USD despite the estimation of −0.78 USD. In the next quarter EPS is expected to reach −0.67 USD. Track more of Rocket Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
According to analysts, RCKT price target is 49.33 USD with a max estimate of 65.00 USD and a min estimate of 39.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with RCKT news and stock market news.
We've gathered opinions of 14 analysts rating RCKT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.